MARK E. RUPPEN
Impact in
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
- Biotechnology top 10%
Papers in
-
- Biochemical and Molecular Research 6
- PI3K/AKT/mTOR signaling in cancer 3
-
- Carbohydrate Chemistry and Synthesis 3
- Co-authors
- Ping Cai (8 shared papers)Jon S. Thorson (3 shared papers)Ross E. Whitwam (2 shared papers)Joachim Ahlert (2 shared papers)Robert L. Switzer (5 shared papers)Eric L. Sievers (1 shared paper)Kenolisa C. Onwueme (1 shared paper)Erica M. Shepard (1 shared paper)
- Journals
- Journal of Bacteriology (4 papers)Journal of Medicinal Chemistry (2 papers)Journal of Natural Products (2 papers)Journal of the American Chemical Society (1 paper)The Journal of Antibiotics (1 paper)
- Partner nations
- United StatesFranceRomania
In The Last Decade
MARK E. RUPPEN
22 papers receiving 688 citations
Peers
Comparison fields: 5 of 76
- Toxicology 44
- Biotechnology 92
- Pharmacology 134
- Organic Chemistry 202
- Molecular Biology 433
Countries citing papers authored by MARK E. RUPPEN
This map shows the geographic impact of MARK E. RUPPEN's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MARK E. RUPPEN with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MARK E. RUPPEN more than expected).
Fields of papers citing papers by MARK E. RUPPEN
This network shows the impact of papers produced by MARK E. RUPPEN. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MARK E. RUPPEN. The network helps show where MARK E. RUPPEN may publish in the future.
Co-authors
The 25 scholars most cited alongside MARK E. RUPPEN, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 151 | |
| 2 | 2000 | 103 | |
| 3 | 2005 | 69 | |
| 4 | 2005 | 60 | |
| 5 | 2009 | 43 | |
| 6 | 2006 | 40 | |
| 7 | 2007 | 37 | |
| 8 | 2005 | 34 | |
| 9 | 2007 | 30 | |
| 10 | 1988 | 29 | |
| 11 | 2000 | 24 | |
| 12 | 1983 | 21 | |
| 13 | 1987 | 19 | |
| 14 | 1983 | 17 | |
| 15 | 2012 | 16 | |
| 16 | 1985 | 13 | |
| 17 | 1983 | 6 | |
| 18 | 1986 | 6 | |
| 19 | 2004 | 6 | |
| 20 | 2010 | 5 |
About MARK E. RUPPEN
MARK E. RUPPEN is a scholar working on Molecular Biology, Organic Chemistry, Pharmacology, Cell Biology and Biotechnology, having authored 22 papers that have together received 732 indexed citations. Recurring topics across this work include Biochemical and Molecular Research (6 papers), Microbial Natural Products and Biosynthesis (5 papers), Enzyme Structure and Function (5 papers), Bacterial Genetics and Biotechnology (3 papers), Hemoglobin structure and function (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Carbohydrate Chemistry and Synthesis (3 papers) and Mast cells and histamine (2 papers). The work is most often cited by research in Toxicology (44 citations), Biotechnology (92 citations), Pharmacology (134 citations), Organic Chemistry (202 citations) and Molecular Biology (433 citations). MARK E. RUPPEN has collaborated with scholars based in United States, France and Romania. Frequent co-authors include Ping Cai, Jon S. Thorson, Ross E. Whitwam, Joachim Ahlert, Robert L. Switzer, Eric L. Sievers, Kenolisa C. Onwueme, Erica M. Shepard, John B. Biggins and David J. Marshall. Their work appears in journals such as Journal of Bacteriology, Journal of Medicinal Chemistry, Journal of Natural Products, Journal of the American Chemical Society and The Journal of Antibiotics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.